research currency- Top Featured snippets

Tin Venture Capital and other companies have invested 300 million yuan in establishing low-altitude economic equity investment partnership. According to Tianyancha App, recently, Wuxi Liangxi Science and Technology City Xichuang Low-altitude economic equity investment partnership (limited partnership) was established. The executive partner is Wuxi Guolian Industrial Investment Private Equity Fund Management Co., Ltd., with a capital contribution of 300 million yuan. Its business scope includes investment activities and venture capital with its own funds, and it is invested by Wuxi Innovation Investment Group Co., Ltd., Wuxi Xiangyun Investment Co., Ltd. and Wuxi Liangxi Science and Technology City.The turnover of Shanghai and Shenzhen stock markets exceeded 1.5 trillion for the 11th consecutive trading day, nearly 70 billion more than yesterday.In the first 11 months of this year, Guangdong's import and export increased by 10% year-on-year. According to statistics from Guangdong Branch of the General Administration of Customs, in the first 11 months of this year, Guangdong's foreign trade import and export reached 8.27 trillion yuan, up by 10% year-on-year, faster than the national growth rate by 5.1 percentage points, accounting for 20.8% of the national total import and export value. Among them, exports were 5.37 trillion yuan, an increase of 8.7%; Imports reached 2.9 trillion yuan, up by 12.6%.

CMB International: Upgraded the target price of WuXi Bio to HK$ 22.88, optimistic about the company's valuation and performance repair. CMB International published a report, predicting that the US Biosafety Act will fail with high probability, which will help WuXi Bio to achieve continuous performance growth in a relatively stable business environment. With the recovery of global biomedical financing, we are optimistic about the company's valuation and performance repair. According to the report, the NDAA in FY 2025 does not include the Biosafety Act, and the legislation of the Biosafety Act failed with high probability. On December 7, the US Senate and the House Armed Services Committee announced the National Defense Authorization Act (NDAA) for fiscal year 2025, which was finally negotiated by the committees of the two houses. The Biosafety Act was not included in the amendment of NDAA in FY 2025, which means that the Biosafety Act failed to pass the legislative path of joining NDAA. The Biosafety Act can still promote separate legislation, but considering that the window of the current US Congress session is less than two weeks, the Bank believes that the success rate of separate legislation is extremely low. CMB International maintained the "Buy" rating of Yaoming Bio, and its target price rose from HK$ 13.58 to HK$ 22.88. It is estimated that the company's revenue will increase by 7.1%/12.4%/ 13.9% from 2024 to 2026, and its adjusted net profit will increase by 0.8%/11.1%/13.4% respectively.Turkish President: It will crack down on organizations such as the PKK in Syria. The Information Bureau of the Turkish Presidential Office issued a statement on the early morning of the 13th, saying that Turkish President Erdogan said that Turkey would take "preventive measures" for national security and crack down on all "terrorist organizations" such as the PKK in Syria.CMB International: Upgraded the target price of WuXi Bio to HK$ 22.88, optimistic about the company's valuation and performance repair. CMB International published a report, predicting that the US Biosafety Act will fail with high probability, which will help WuXi Bio to achieve continuous performance growth in a relatively stable business environment. With the recovery of global biomedical financing, we are optimistic about the company's valuation and performance repair. According to the report, the NDAA in FY 2025 does not include the Biosafety Act, and the legislation of the Biosafety Act failed with high probability. On December 7, the US Senate and the House Armed Services Committee announced the National Defense Authorization Act (NDAA) for fiscal year 2025, which was finally negotiated by the committees of the two houses. The Biosafety Act was not included in the amendment of NDAA in FY 2025, which means that the Biosafety Act failed to pass the legislative path of joining NDAA. The Biosafety Act can still promote separate legislation, but considering that the window of the current US Congress session is less than two weeks, the Bank believes that the success rate of separate legislation is extremely low. CMB International maintained the "Buy" rating of Yaoming Bio, and its target price rose from HK$ 13.58 to HK$ 22.88. It is estimated that the company's revenue will increase by 7.1%/12.4%/ 13.9% from 2024 to 2026, and its adjusted net profit will increase by 0.8%/11.1%/13.4% respectively.

CICC: It is expected that the central bank will further set up other new monetary instruments in the future. CICC said that on the basis of Politburo meeting of the Chinese Communist Party, the policy objectives and directions of the Central Economic Work Conference have been further stated. For next year's economic goals, after "maintaining stable economic growth", the meeting proposed to "maintain overall stability in employment and prices" and pointed out that "we should pay attention to target guidance and strive to achieve an optimal combination of stable growth, stable employment and reasonable price recovery". In terms of monetary policy, CICC believes that this meeting clearly pointed out that "timely RRR cuts and interest rate cuts". It is expected that in order to meet the government bond issuance, credit supply and seasonal liquidity demand, the RRR cut may be implemented before the Spring Festival, and the interest rate cut may also be gradually promoted with the Fed's interest rate cut. CICC also judged that in the past period, the central bank has established new monetary instruments such as treasury bonds trading tools, securities fund insurance company exchange facilities, and affordable housing refinancing, and its ability to play a role in the stock, bond, real estate and other markets has been strengthened, and other new instruments may be further established in the future. (SSE)The space robot won the TGA annual game "Black Myth Wukong", the TGA award ceremony is in progress, and "Astro Bot" won the TGA annual game. Other nominated games include Black Myth: Wukong, Clown Card, Eldon Circle: The Shadow of Huang Jinshu, Final Fantasy 7: Rebirth, Metaphorical Fantasy: Refantazio. Cosmic Robot is a game work developed by Team ASOBI and released by Sony Interactive Entertainment. Players and ASTRO have launched a brand-new super-large adventure trip to explore more than 50 exciting and varied worlds. The release of the game coincides with the 30th anniversary of PlayStation game console, and a lot of tribute elements have been added to the game works, which has also become one of the reasons why the game attracts worldwide attention. (Sina Technology)"Black Myth: Wukong" won two TGA awards and is competing for the best game of the year. On December 13th, the reporter learned that at the TGA(The Game Awards)2024 award ceremony, the domestic game "Black Myth: Wukong" won the best action game and the player's voice award, and the best game award is in the competition. Jiang Baicun, the director of the planning of Black Myth: Wukong, said in his acceptance speech: "It is a great honor to win this award. First of all, I want to thank every player. It is your support that makes such an oriental myth about courage and wisdom shine on such a stage. I also want to thank the organizers for not setting up an' air wall' during my coming to power." (Dahe Finance Cube)